WHO to Restart Hydroxychloroquine Trial as Risks Questioned

(Bloomberg) -- An international trial using hydroxychloroquine to treat Covid-19 patients will be restarted after questions arose about a study linking the antimalarial drug to increased death and ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.